Design of PD-L1 inhibitors for lung cancer

The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interes...

Descripción completa

Detalles Bibliográficos
Autores principales: Udhwani, Trishang, Mukherjee, Sourav, Sharma, Khushboo, Sweta, Jajoriya, Khandekar, Natasha, Nayarisseri, Anuraj, Singh, Sanjeev Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677907/
https://www.ncbi.nlm.nih.gov/pubmed/31435160
http://dx.doi.org/10.6026/97320630015139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677907/
https://www.ncbi.nlm.nih.gov/pubmed/31435160
http://dx.doi.org/10.6026/97320630015139

Ejemplares similares